| Ref ID | 723 |
| First Author | I.X.Y. Wu |
| Journal | ANNALS OF THE AMERICAN THORACIC SOCIETY |
| Year Of Publishing | 2020 |
| URL | https://dx.doi.org/10.1513/AnnalsATS.202003-187OC |
| Keywords |
• Immunology • Non-Cochrane reviews • Low reporting quality • Publication bias • Expertise • Cochrane • Low methodological quality • Disclosure • Risk of bias • Protocols |
| Problem(s) |
• No registered or published protocol • Low methodological (AMSTAR) quality • Conflicts of interest or funding of included studies not assessed • Cochrane reviews more rigorous/higher quality than non-Cochrane reviews • Reasons for excluding potentially eligible studies not provided • Lack of statistical expertise in handling of quantitative data • Poor consideration of publication bias • Meta-analyses and forest plots presented without considering risk of bias / quality |
| Article Type | Empirical |
| Article Subtype | Cross-sectional survey/Methodological systematic review |
| First Author Country | China |
| Checklists |
• AMSTAR 2 |
| Aim | To assess the methodological quality of systematic reviews of asthma treatment published between 2013 and 2019 using AMSTAR 2. |
| Level of Investigation | Analytical |
| Summary of Findings | From 126 included systematic reviews of asthma treatment, 23.5% of reviews were of low methodological quality and 61% were of critically low quality. Cochrane reviews and reviews with a European corresponding author were significantly more likely to be high quality than non-Cochrane systematic reviews or reviews with a corresponding author from America, Asia or Oceania.. |
| Number of systematic reviews included | 136 |
| Number of eligible systematic reviews assessed | 2242 |